University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma

Simple item page
dc.contributor.authorBaxter, M. A.
dc.contributor.authorSpender, L. C.
dc.contributor.authorCairns, D.
dc.contributor.authorWalsh, S.
dc.contributor.authorOparka, R.
dc.contributor.authorPorter, R. J.
dc.contributor.authorBray, S.
dc.contributor.authorSkinner, G.
dc.contributor.authorKing, S.
dc.contributor.authorTurbitt, J.
dc.contributor.authorCollinson, D.
dc.contributor.authorMiedzybrodzka, Z. H.
dc.contributor.authorJellema, G.
dc.contributor.authorLogan, G.
dc.contributor.authorKennedy, R. D.
dc.contributor.authorTurkington, R. C.
dc.contributor.authorMcLean, M. H.
dc.contributor.authorSwinson, D.
dc.contributor.authorGrabsch, H. I.
dc.contributor.authorLord, S.
dc.contributor.authorSeymour, M. J.
dc.contributor.authorHall, P. S.
dc.contributor.authorPetty, R. D.
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2024-07-25T11:02:01Z
dc.date.available2024-07-25T11:02:01Z
dc.date.issued2024-05
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent1152752
dc.identifier291806293
dc.identifiereb5f1718-b758-427b-848d-90d3dfdb3b50
dc.identifier85192856522
dc.identifier38744099
dc.identifier38744099
dc.identifier.citationBaxter, M A, Spender, L C, Cairns, D, Walsh, S, Oparka, R, Porter, R J, Bray, S, Skinner, G, King, S, Turbitt, J, Collinson, D, Miedzybrodzka, Z H, Jellema, G, Logan, G, Kennedy, R D, Turkington, R C, McLean, M H, Swinson, D, Grabsch, H I, Lord, S, Seymour, M J, Hall, P S & Petty, R D 2024, 'An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma', ESMO Open, vol. 9, no. 5, 103450. https://doi.org/10.1016/j.esmoop.2024.103450en
dc.identifier.doi10.1016/j.esmoop.2024.103450
dc.identifier.iss5en
dc.identifier.issn2059-7029
dc.identifier.otherORCID: /0000-0002-7443-2653/work/164506351
dc.identifier.otherORCID: /0000-0003-2890-8136/work/175113449
dc.identifier.urihttps://hdl.handle.net/2164/23915
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85192856522&partnerID=8YFLogxKen
dc.identifier.vol9en
dc.language.isoeng
dc.relation.ispartofESMO Openen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectDNA damage immune responseen
dc.subjectepidermal growth factor receptoren
dc.subjectgastroesophageal adenocarcinomaen
dc.subjectimmune checkpoint inhibitorsen
dc.subjecttumour microenvironmenten
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectOncologyen
dc.subjectCancer Researchen
dc.subject.lccRC0254en
dc.titleAn investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinomaen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Baxter_etal_ESMOO_An_Investigation_of_the_VOR.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
Download

Collections

All research